Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-09

Clinical Trial Update: Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS [NA]

View source ↗

Summary

A completed clinical trial comparing 20 microgram versus 30 microgram drospirenone-ethinyl estradiol and its effect on the free androgen index in polycystic ova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Drospirenone-Ethinyl Estradiol (Drospirenone and Ethinyl Estradiol)

Snippet

Sponsor: Mst.Sumyara Khatun | Conditions: PCOS (Polycystic Ovary Syndrome) | NA | Status: COMPLETED